Search Results 821-830 of 15269 for alt

1. PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial

   ALT/AST >= 3 x ULN; Bilirubin >= 3 mg/dL at Screening; Any known factor or disease that might interfere with treatment compliance, study conduct, or ...

2. Paget's disease of bone - Diagnosis & treatment - Mayo Clinic

   Find out about this condition that can make bones fragile and misshapen, along with the osteoporosis drugs that can treat it.

3. Statins and CPAP in Adipose Tissue of OSA - Mayo Clinic

   Elevated ALT (> 3 times upper normal limit). Fasting glucose > 120 mg/dL and/or HbA1c ≥ 6.5%. Females planning to be pregnant in next six months. Known ...

4. Study of Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer - Mayo Clinic

   ALT and AST ≤ 3 × ULN. Abbreviations: ALT = alanine aminotransferase; ANC = absolute neutrophil count; AST = aspartate aminotransferase; G-CSF = granulocyte ...

5. A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) - Mayo Clinic

   Serum AST and/or alanine aminotransferase (ALT) < 3 x institutional upper limit of normal (ULN). Participant has left ventricular ejection fraction (LVEF) ...

6. Safety of MT-401-OTS in Patients with Relapsed AML or MDS - Mayo Clinic

   AST and ALT < 3 × ULN; for participants with leukemic infiltration of the liver (documented by biopsy or imaging), AST and ALT < 5 × ULN is permitted. Total ...

7. A Study to Evaluate Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant - Mayo Clinic

   AST or ALT > 2.5 x Upper Limit of Normal at the local institution's laboratory;; History of drug, alcohol, or chemical abuse within 6 months prior to ...

8. Enhancing Adaptations to Exercise - Clinical Trials

   Chronic active liver disease (AST>144 IU/L or ALT>165 IU/L); Oral warfarin group medications or history of blood clotting disorders. international normalized ...

9. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

   Abbreviations: ALT = alanine aminotransferase; AST = aspartate aminotransferase; CrCl = creatinine clearance; GFR = glomerular filtration rate; INR ...

10. Combination Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Young Patients with Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma - Mayo Clinic

    AST and ALT < 2 times ULN; Shortening fraction ≥ 27% by echocardiogram; Ejection fraction ≥ 47% by radionuclide angiogram; No evidence of dyspnea at rest ...